8-K
filed January 6, 2026, 6:59 PM ET
ticker KALA
CIK 0001479419
other material
confidence high
sentiment positive
materiality 0.70
KALA BIO settles $10.6M Oxford debt for $2M; issues 4.6M shares to settle claims
KALA BIO, Inc.
- Paid $2M to Oxford Finance, settling ~$10.6M debt obligations in full; debt overhang removed.
- Issued 900,000 shares to Baker Bros. to resolve participation rights claims under prior financing.
- Issued 2,200,000 shares to LifeSci Capital for unpaid financial advisory services.
- Issued 1,100,000 shares to Delaware IR to settle $600,000 consulting fee; make-whole provision.
- Total 4,600,000 shares issued in private, unregistered transactions (incl. 400,000 to employees).
Key facts
Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
KALA BIO, Inc. issued 1,100,000 shares of common stock to Delaware IR LLC for settlement of the outstanding $600,000 amount owed under the consulting agreement.
- Security
- common stock
- Shares
- 1,100,000 shares
- Purchaser
- Delaware IR LLC
- Consideration
- settlement of the outstanding $600,000 amount owed under the consulting agreement
Exact text from the filing
agreement with Delaware IR LLC (“Delaware IR”). Under the consulting agreement, Delaware IR agreed to provide marketing and advertising services for a six-month term for $600,000. Under the settlement agreement, the Company agreed to issue 1,100,000 shares of Common Stock to settle the outstanding $600,000 amount owed under the consulting agreement, with
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
KALA BIO, Inc. entered into Baker Voting Agreement with Baker Bros. Advisors LP valued at Granted irrevocable proxy for six months (effective 2025-12-30).
- Action
- entry
- Counterparty
- Baker Bros. Advisors LP
- Value
- Granted irrevocable proxy for six months
- Effective
- 2025-12-30
Exact text from the filing
In connection with the Baker Settlement, the Company and Baker Bros. also entered into a voting agreement (the “Baker Voting Agreement”) under which Baker Bros. granted an irrevocable proxy in favor of the Company to vote the settlement shares and other specified shares in line with the Company’s board of director’s recommendations for a period of six months.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
KALA BIO, Inc. entered into Delaware IR Settlement with Delaware IR LLC valued at Issued 1,100,000 shares of common stock to settle $600,000 owed (effective 2025-12-30).
- Action
- entry
- Agreement
- settlement
- Counterparty
- Delaware IR LLC
- Value
- Issued 1,100,000 shares of common stock to settle $600,000 owed
- Effective
- 2025-12-30
Exact text from the filing
Under the settlement agreement, the Company agreed to issue 1,100,000 shares of Common Stock to settle the outstanding $600,000 amount owed under the consulting agreement, with a make-whole mechanic tied to ultimate net sale proceeds from the future sales of the 1,100,000 shares of Common Stock (the “Delaware IR Settlement”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
KALA BIO, Inc. entered into LifeSci Settlement with LifeSci Capital LLC valued at Issued 2,200,000 shares of common stock (effective 2025-12-30).
- Action
- entry
- Agreement
- settlement
- Counterparty
- LifeSci Capital LLC
- Value
- Issued 2,200,000 shares of common stock
- Effective
- 2025-12-30
Exact text from the filing
On December 30, 2025, the Company also entered into a settlement agreement with LifeSci Capital LLC (“LifeSci”) under which the Company agreed to issue 2,200,000 shares of Common Stock to settle certain payment obligations for financial advisory services (the “LifeSci Settlement”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
KALA BIO, Inc. entered into Delaware IR Consulting Agreement with Delaware IR LLC valued at Marketing and advertising services for six months for $600,000 (effective 2025-12-30).
- Action
- entry
- Agreement
- settlement
- Counterparty
- Delaware IR LLC
- Value
- Marketing and advertising services for six months for $600,000
- Effective
- 2025-12-30
Exact text from the filing
On December 30, 2025, the Company also entered into a consulting agreement and a settlement agreement with Delaware IR LLC (“Delaware IR”). Under the consulting agreement, Delaware IR agreed to provide marketing and advertising services for a six-month term for $600,000.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
KALA BIO, Inc. entered into Baker Settlement with Baker Bros. Advisors LP valued at Issued 900,000 shares of common stock (effective 2025-12-30).
- Action
- entry
- Agreement
- settlement
- Counterparty
- Baker Bros. Advisors LP
- Value
- Issued 900,000 shares of common stock
- Effective
- 2025-12-30
Exact text from the filing
On December 30, 2025, KALA BIO, Inc. (the “Company”) entered into a settlement agreement with Baker Bros. Advisors LP (“Baker Bros.”) under which the Company agreed to issue 900,000 shares of its common stock, par value $0.001 per share (“Common Stock”) to resolve certain claims relating to participation rights under prior financing arrangements (the “Baker Settlement”).
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.